RHCE and Kell genotyping and alloimmunization profile in patients with sickle cell disease in the Federal District of Brazil
Open Access
- 16 June 2023
- journal article
- research article
- Published by Elsevier in Hematology, Transfusion and Cell Therapy
- Vol. 46 (3) , 261-267
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Risk factors for red blood cell alloimmunization in the Recipient Epidemiology and Donor Evaluation Study (REDS‐III) databaseBritish Journal of Haematology, 2018
- Application of genomics for transfusion therapy in sickle cell anemiaBlood Cells, Molecules, and Diseases, 2017
- Alloimmunisation rates of sickle cell disease patients in the United States differ from those in other geographical regionsTransfusion Medicine, 2016
- Female sex of older patients is an independent risk factor for red blood cell alloimmunization after transfusionTransfusion, 2015
- High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donorsBlood, 2013
- Red‐blood‐cell alloimmunization and number of red‐blood‐cell transfusionsVox Sanguinis, 2011
- Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunizationTransfusion, 2009
- DNA array analysis for red blood cell antigens facilitates the transfusion support with antigen‐matched blood in patients with sickle cell diseaseVox Sanguinis, 2009
- DNA‐based typing of blood groups for the management of multiply‐transfused sickle cell disease patientsTransfusion, 2002
- Red cell antibodies in patients with homozygous sickle cell disease: a comparison of patients in Jamaica and the United KingdomBritish Journal of Haematology, 2001